GlucoTrack logo

GlucoTrack

GCTK | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.31 (-38.75%)
At close: Nov 2, 2026, 3:47 PM ET
-38.75%

Rating

Updated: Nov 2, 2026
30.8
+1.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #6/11 (Top 55%)

Key Statistics

Market Data

Market Cap $195.55K
1D Range
0.49 0.76
52W Range
0.49 102.00

Valuation (TTM)

PE 0
PB -0.11
EV/EBITDA 0.06

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Loading financial charts...

Profile

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBG...

Sector Healthcare
Employees 15
IPO Date Apr 25, 2013
Fiscal Year January - December

Latest News

Glucotrack, Inc. Announces Reverse Stock Split

26 days ago · businesswire.com

Glucotrack, Inc. Announces Reverse Stock Split
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

2 months ago · gurufocus.com

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket

2 months ago · benzinga.com

Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities

2 months ago · businesswire.com

Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

2 months ago · gurufocus.com

Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
Glucotrack Announces $11.5 Million Financing

2 months ago · gurufocus.com

Glucotrack Announces $11.5 Million Financing
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

3 months ago · businesswire.com

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.